Published in J Virol on December 01, 1997
Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95
Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52
Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev (2006) 2.36
Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J (2000) 1.73
CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol (2003) 1.72
The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. J Virol (2005) 1.57
Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol (2003) 1.37
The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association. J Virol (2000) 1.37
Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability. J Biol Chem (2008) 1.36
The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol (1999) 1.32
Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J Virol (2000) 1.27
Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression. J Virol (2010) 1.22
Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J Virol (2001) 1.19
Brd4-independent transcriptional repression function of the papillomavirus e2 proteins. J Virol (2007) 1.19
Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J Virol (2000) 1.17
The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J Virol (2000) 1.15
Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol (2003) 1.11
Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J Virol (2002) 1.10
Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells. Proc Natl Acad Sci U S A (2003) 1.05
The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31. J Virol (2001) 1.05
High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology (2006) 1.05
Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol (2002) 1.04
Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology (2008) 1.04
E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J Virol (2006) 1.03
Small molecule inhibitors of human papillomavirus protein - protein interactions. Open Virol J (2011) 0.97
Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res (2007) 0.96
Papillomavirus interaction with cellular chromatin. Biochim Biophys Acta (2009) 0.96
mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication. J Virol (2003) 0.95
The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase. J Virol (2010) 0.93
Interaction of papillomavirus E2 protein with the Brm chromatin remodeling complex leads to enhanced transcriptional activation. J Virol (2006) 0.93
Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. Am J Cancer Res (2011) 0.91
Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J Virol (2002) 0.90
Identification and analysis of papillomavirus E2 protein binding sites in the human genome. J Virol (2011) 0.90
Interferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells. PLoS One (2013) 0.90
Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs). Virology (2008) 0.89
Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma. Biochem J (2012) 0.86
The HPV E2-Host Protein-Protein Interactions: A Complex Hijacking of the Cellular Network. Open Virol J (2012) 0.86
Inhibition of human papilloma virus E2 DNA binding protein by covalently linked polyamides. Nucleic Acids Res (2003) 0.86
Host cell sumoylation level influences papillomavirus E2 protein stability. Virology (2009) 0.85
Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes. J Virol (2009) 0.83
Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression. J Virol (2012) 0.82
Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression. J Virol (2010) 0.81
Human papillomavirus induced transformation in cervical and head and neck cancers. Cancers (Basel) (2014) 0.79
Post-Transcriptional Regulation of KLF4 by High-Risk Human Papillomaviruses Is Necessary for the Differentiation-Dependent Viral Life Cycle. PLoS Pathog (2016) 0.79
Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther (2007) 0.79
Replication and transcription of human papillomavirus type 58 genome in Saccharomyces cerevisiae. Virol J (2010) 0.78
The Role of F-Box Proteins during Viral Infection. Int J Mol Sci (2013) 0.77
Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs. Int J Mol Sci (2017) 0.75
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature (1990) 7.11
Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J (1991) 6.00
Binding of general transcription factor TFIIB to an acidic activating region. Nature (1991) 4.71
Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell (1993) 4.57
Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature (1992) 4.12
The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication. Cell (1993) 3.68
Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies. Nucleic Acids Res (1991) 3.48
Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol (1994) 3.46
Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev (1989) 3.41
Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J (1994) 3.27
E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proc Natl Acad Sci U S A (1989) 3.18
Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol (1990) 2.90
The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev (1991) 2.24
A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target. EMBO J (1988) 2.22
Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J Virol (1987) 2.21
Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol (1995) 2.05
Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol (1991) 2.02
Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J Virol (1993) 1.92
Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol (1994) 1.90
Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J (1997) 1.85
Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. J Virol (1988) 1.85
During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res (1992) 1.69
The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol (1990) 1.68
Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol (1997) 1.59
The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site affinity. Virology (1990) 1.53
The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. EMBO J (1995) 1.50
Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J Virol (1995) 1.48
Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J (1994) 1.37
Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J Virol (1993) 1.36
The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter. J Virol (1994) 1.28
High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology (1996) 1.27
Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer (1994) 1.20
Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1. Nucleic Acids Res (1992) 1.12
Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements. Nucleic Acids Res (1994) 0.97
Early promoters of genital and cutaneous human papillomaviruses are differentially regulated by the bovine papillomavirus type 1 E2 gene product. J Gen Virol (1992) 0.86
Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell (1984) 9.47
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J (1996) 6.36
A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J (1993) 5.26
Absence of nucleosomes in a fraction of SV40 chromatin between the origin of replication and the region coding for the late leader RNA. Cell (1980) 5.20
Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature (1988) 5.04
Factors involved in control of tissue-specific expression of albumin gene. Cell (1987) 4.39
Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J (1982) 4.13
E. coli DNA binding protein HU forms nucleosomelike structure with circular double-stranded DNA. Cell (1979) 4.07
Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell (1996) 4.05
Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J (1998) 3.99
The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J (1987) 3.86
Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region. Cell (1980) 3.63
CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep (2001) 3.55
Characterization of junD: a new member of the jun proto-oncogene family. EMBO J (1989) 3.55
Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells. Nature (1981) 3.47
Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci U S A (1991) 3.45
The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep (2000) 3.30
Specific interaction of cellular factors with the B enhancer of polyoma virus. EMBO J (1985) 3.23
A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron (1995) 3.11
Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J (1987) 3.09
Tissue-specific expression is conferred by a sequence from the 5' end of the rat albumin gene. EMBO J (1984) 3.07
Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J (1988) 3.01
Several distinct "CCAAT" box binding proteins coexist in eukaryotic cells. Proc Natl Acad Sci U S A (1988) 3.01
A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes Dev (1988) 2.97
Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol (1990) 2.90
Chromatin-like structures in polyoma virus and simian virus 10 lytic cycle. J Virol (1975) 2.82
The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J (1996) 2.71
Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes. J Virol (1983) 2.69
Assembly of transfected DNA into chromatin: structural changes in the origin-promoter-enhancer region upon replication. EMBO J (1984) 2.69
Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J (2000) 2.66
Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells. Nature (1987) 2.65
RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci U S A (1997) 2.53
Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system. Mol Cell Biol (1987) 2.52
Fine structure of the origin-proximal DNAase I-hypersensitive region in wild-type and EC mutant polyoma. Cell (1981) 2.52
Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J Cell Biol (1997) 2.50
The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J Virol (1989) 2.50
Analysis of the distribution of binding sites for a tissue-specific transcription factor in the vertebrate genome. J Mol Biol (1997) 2.47
Fine structure of the cottontail rabbit papillomavirus mRNAs expressed in the transplantable VX2 carcinoma. J Virol (1985) 2.40
Genomic structure of the cottontail rabbit (Shope) papillomavirus. Proc Natl Acad Sci U S A (1985) 2.40
Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. Proc Natl Acad Sci U S A (1988) 2.24
The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev (1991) 2.24
A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target. EMBO J (1988) 2.22
Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J Virol (1987) 2.21
vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J (1991) 2.19
Regulation of eukaryotic gene expression by transactivating proteins and cis acting DNA elements. Biol Cell (1984) 2.13
The mammalian Jun proteins: redundancy and specificity. Oncogene (2001) 2.13
Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes (2001) 2.08
A single mutational modification of a tryptophan-specific transfer RNA permits aminoacylation by glutamine and translation of the codon UAG. J Mol Biol (1974) 2.05
[Thermosensitive mutations of systems activating valine in E. coli]. Bull Soc Chim Biol (Paris) (1965) 2.02
Induction of apoptosis by the transcription factor c-Jun. EMBO J (1997) 2.02
HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays (1992) 2.01
Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell (1994) 2.00
JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell (2000) 1.99
A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. Nucleic Acids Res (1995) 1.92
Structure of transfer RNA. Evidence for interaction between two non-adjacent nucleotide residues in tRNA from Escherichia coli. Nature (1969) 1.90
Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest (1998) 1.86
Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J (1997) 1.85
Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. J Virol (1988) 1.85
Transformation by ras modifies AP1 composition and activity. Oncogene (1997) 1.80
When the SWI/SNF complex remodels...the cell cycle. Oncogene (2001) 1.79
Enhancing elements for activation of eukaryotic promoters. Nature (1982) 1.74
A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. Nucleic Acids Res (1990) 1.73
Nucleotide sequence of E. coli B tRNA1-Val. Nature (1969) 1.71
Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene (2007) 1.70
ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J Mol Biol (1999) 1.69
Fine structure of the regulatory region of simian virus 40 minichromosomes revealed by DNAase I digestion. J Mol Biol (1982) 1.68
Constitutive synthesis of activator protein 1 transcription factor after viral transformation of mouse fibroblasts. Proc Natl Acad Sci U S A (1988) 1.67
Molecular cloning, refined physical map and heterogeneity of methylation sites of papilloma virus type 1a DNA. Eur J Biochem (1980) 1.64
Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance. Mol Cell Biol (1990) 1.63
Hepatic nuclear factor 1 (HNF1) shows a wider distribution than products of its known target genes in developing mouse. Development (1991) 1.62
Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol (1992) 1.59
Both Jun and Fos contribute to transcription activation by the heterodimer. Oncogene (1990) 1.59
ras transformation is associated with decreased expression of the brm/SNF2alpha ATPase from the mammalian SWI-SNF complex. EMBO J (1998) 1.59
Expression of the vHNF1/HNF1beta homeoprotein gene during mouse organogenesis. Mech Dev (1999) 1.58
Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J (2001) 1.55
DNA replication origin of polyoma virus: early proximal boundary. J Virol (1983) 1.54
The rat albumin promoter: cooperation with upstream elements is required when binding of APF/HNF1 to the proximal element is partially impaired by mutation or bacterial methylation. Mol Cell Biol (1989) 1.53
Hepatocyte dedifferentiation and extinction is accompanied by a block in the synthesis of mRNA coding for the transcription factor HNF1/LFB1. EMBO J (1990) 1.51
The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. EMBO J (1995) 1.50
Human papillomavirus DNA: physical map. Proc Natl Acad Sci U S A (1975) 1.49
Essential role for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentiation. Development (1999) 1.49
The activity of mammalian brm/SNF2alpha is dependent on a high-mobility-group protein I/Y-like DNA binding domain. Mol Cell Biol (1999) 1.48
Bidirectional transcription and the regulation of Phage lambda repressor synthesis. Proc Natl Acad Sci U S A (1972) 1.45
The papillomavirus E2 protein: a factor with many talents. Trends Biochem Sci (1991) 1.44
Stress-activated protein kinases are negatively regulated by cell density. EMBO J (1998) 1.43
Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol (2001) 1.43
Comparative small-angle x-ray scattering studies on unacylated, acylated and cross-linked Escherichia coli transfer RNA I Val . J Mol Biol (1972) 1.43
A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation. EMBO J (2001) 1.41
Functional analysis of the papilloma virus E2 trans-activator in Saccharomyces cerevisiae. Genes Dev (1989) 1.40
Physical and biological features of polyoma virus mutants able to infect embryonal carcinoma cell lines. J Virol (1982) 1.39
More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing. EMBO J (1993) 1.38
Papillomavirus genomes: sequences and consequences. J Invest Dermatol (1984) 1.38
Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses. J Virol (1988) 1.37